These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17009337)

  • 21. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of mifepristone in capsule versus tablet form in healthy nonpregnant women.
    Liao A; Pang X; Li H; Xiong Z; Wu X
    Contraception; 2008 Jun; 77(6):431-4. PubMed ID: 18477493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outdated EpiPen and EpiPen Jr autoinjectors: past their prime?
    Simons FE; Gu X; Simons KJ
    J Allergy Clin Immunol; 2000 May; 105(5):1025-30. PubMed ID: 10808186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of binders on the bioavailability of ofloxacin tablets in animal model.
    Rasool F; Ahmad M; Khan HM; Akhtar N; Murtaza G
    Acta Pol Pharm; 2010; 67(2):185-9. PubMed ID: 20369796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet.
    Ibáñez Y; Rodríguez JM; Luján M; Grattan TJ; Martin AJ; Burnett I
    Curr Med Res Opin; 2006 Oct; 22(10):1893-7. PubMed ID: 17022846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
    Lissy M; Stiff DD; Kowalski MM; Moore KA
    Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
    Kayitare E; Vervaet C; Ntawukulilyayo JD; Seminega B; Bortel V; Remon JP
    Int J Pharm; 2009 Mar; 370(1-2):41-6. PubMed ID: 19059324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
    Reiz JL; Donnelly GA; Michalko K
    Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers.
    Armando YP; Schramm SG; Silva Mde F; Kano EK; Koono EE; Porta V; Serra CH
    Int J Pharm; 2009 Jan; 366(1-2):149-53. PubMed ID: 18848869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations.
    Matthias A; Addison RS; Agnew LL; Bone KM; Watson K; Lehmann RP
    Phytomedicine; 2007 Sep; 14(9):587-90. PubMed ID: 17289362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.
    Rawas-Qalaji MM; Werdy S; Rachid O; Simons FE; Simons KJ
    AAPS PharmSciTech; 2015 Oct; 16(5):1203-12. PubMed ID: 25732373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
    AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
    Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
    J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.